The cells derived from adipose-derived stem cells were intended to target hardening of the arteries and diabetes. Five consecutive reviews by MHLW evaluation committees came to the conclusion that the experimental plans required further modifications, and the Clinic finally decided to opt out.

Nikkei Biotech, June 6, 2016